Position in HROW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,035,835
-$779,922 QoQ
Shares Held
142,120
-26.5% QoQ
Ownership
0.379%
of shares outstanding
% of Portfolio
1.88%
of 13F equity value
Holder Rank
#27
of 221 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Derivatives in HROW
reported options exposure · as of Mar 31, 2026CallValue
$176,300
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Crawford Fund Management, LLC holds $13,279,017 across 2 Drug Manufacturers - Specialty & Generic names. HROW ranks #2 (45.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
13,368 | $7,243,182 | |
| 2 | HROW |
Harrow, Inc.
This page
|
142,120 | $6,035,835 |
All Filings in HROW
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,035,835 | 142,120 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $176,300 | 5,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $6,815,757 | 193,300 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $392,000 | 8,000 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $5,066,600 | 103,400 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $335,500 | 10,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $449,600 | 10,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $208,900 | 10,000 | Call | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||